• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,264.33 736.38
( 0.97%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
69,318.21 3,298.17
(5.00%)
Nikkei 225
10,435.69 -36.03
(-0.34%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Mangalam Drugs and Organics Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532637
INE584F01014
65.2745951
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MANGALAM
0
44.49
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Ridhi Synthetics standalone net profit declines 11.76% in the March 2026 quarter
May 28,2026
Net profit of Ridhi Synthetics declined 11.76% to Rs 0.15 crore in the quarter ended March 2026 as against Rs 0.17 crore during the previous quarter ended March 2025. Sales rose 9.09% to Rs 0.12 crore in the quarter ended March 2026 as against Rs 0.11 crore during the previous quarter ended March 2025.

For the full year,net profit declined 25.23% to Rs 0.80 crore in the year ended March 2026 as against Rs 1.07 crore during the previous year ended March 2025. Sales rose 16.28% to Rs 0.50 crore in the year ended March 2026 as against Rs 0.43 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.120.11 9 0.500.43 16
OPM %-33.33-45.45 --28.00-34.88 -
PBDT0.210.23 -9 1.131.48 -24
PBT0.190.22 -14 1.061.43 -26
NP0.150.17 -12 0.801.07 -25